- <![CDATA[Dr Lee on Research Collaborations Studying PD-L1 as a Biomarker in NSCLC]]><![CDATA[Jonathan Wennan Lee, MD, MSc, discusses future directions for studying PD-L1 as a predictive biomarker in EGFR-mutated NSCLC. ]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myeloma]]><![CDATA[Ajai Chari, MD, discusses frontline treatment and transplant considerations in multiple myeloma.]]>onclive · 2mo ago↗ source
- Lilly plans new $4.5B manufacturing investment in IndianaEli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana as drugmakers pledge more US projects. The world’s largest pharma company, headquart…Endpoints